Stock HCAT HEALTH CATALYST, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Health Catalyst, Inc.

Equities

HCAT

US42225T1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
6.03 USD +7.68% Intraday chart for Health Catalyst, Inc. +8.06% -34.88%
Apr. 11 North American Morning Briefing : Stock Futures -2- DJ
Apr. 10 KeyBanc Downgrades Health Catalyst to Sector Weight From Overweight on Potential Risks to Hospital End Markets MT

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company appears to be poorly valued given its net asset value.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company has insufficient levels of profitability.
  • One of the major weak points of the company is its financial situation.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
HEALTH CATALYST, INC. Stock Health Catalyst, Inc.
-34.88% 353M
C
ADOBE INC. Stock Adobe Inc.
-19.95% 214B
B
WORKDAY INC. Stock Workday Inc.
-9.06% 66.6B
B-
ROPER TECHNOLOGIES, INC. Stock Roper Technologies, Inc.
-3.37% 56.39B
B
AUTODESK, INC. Stock Autodesk, Inc.
-10.49% 46.62B
A-
DATADOG, INC. Stock Datadog, Inc.
+8.30% 43.93B
C
ELECTRONIC ARTS INC. Stock Electronic Arts Inc.
-6.51% 34.19B
B
ANSYS, INC. Stock ANSYS, Inc.
-7.95% 29.14B
B
APPLOVIN CORPORATION Stock AppLovin Corporation
+85.24% 24.32B -
PTC INC. Stock PTC Inc.
+3.45% 21.64B
B
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HCAT Stock
  4. Ratings Health Catalyst, Inc.